Skip to main content

Diabetes complications and comorbidities

Bone health

09-07-2020 | Bone health | News

Type 2 diabetes adversely affects bone mass in youth

Youth with type 2 diabetes have lower areal bone mineral density than those with obesity or who are of normal weight, according to the results of a cross-sectional study.

02-12-2020 | Older adults | News

Increasing comorbidity linked to poorer care quality for older people with diabetes

The quality of care among older adults with diabetes declines with increasing comorbidity and is particularly low for those with both osteoarthritis and major depression, population-based study data show.

01-21-2019 | Bone health | News

Poor glycemic control has diabetes type-specific effect on fracture risk

Poor glycemic control is associated with an increased risk for low-trauma fracture in people with type 1, but not type 2, diabetes, study findings indicate.

01-02-2019 | Canagliflozin | medwireNews | News

No fracture risk found with canagliflozin in real-world data

Research based on insurance claims data indicates that new users of the sodium-glucose cotransporter-2 inhibitor canagliflozin are no more likely to experience a fracture than new users of glucagon-like peptide-1 receptor agonists.

08-18-2018 | Bone health | Review | Article

Lifestyle management of diabetes: implications for the bone-vascular axis

Pieralice S et al. Curr Diab Rep 2018; 18: 84. doi: 10.1007/s11892-018-1060-y

07-23-2018 | SGLT2 inhibitors | Review | Article

SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice

Wilding J et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0471-8

07-06-2018 | Osteoporosis | Article

FRAX tool in type 2 diabetic subjects: The use of HbA1c in estimating fracture risk

Valentini A et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1187-y

04-25-2018 | Bone health | Review | Article

Diabetes mellitus and bone health: Epidemiology, etiology and implications for fracture risk stratification

Valderrábano RJ, Linares MI. Clin Diabetes Endocrinol 2018; 4: 9. doi: 10.1186/s40842-018-0060-9

02-06-2018 | Osteoporosis | Review | Article

Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: A systematic review

Anagnostis P et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1548-x

01-20-2018 | Osteoporosis | Article

Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus

DeShields SC, Cunningham TD. J Endocrinol Invest 2018; Advance online publication. doi: 10.1007/s40618-018-0828-x

04-27-2017 | Osteoporosis | Review | Article

Diabetes, bone and glucose-lowering agents: Clinical outcomes

Schwartz AV. Diabetologia 2017; 60: 1170–1179. doi: 10.1007/s00125-017-4283-6

04-22-2017 | Osteoporosis | Review | Article

Diabetes, bone and glucose-lowering agents: Basic biology

Lecka-Czernik B. Diabetologia 2017; 60: 1163–1169. doi: 10.1007/s00125-017-4269-4

03-14-2017 | Bone health | Article

Imaging of diabetic bone

Ponti F et al. Endocrine 2017; 3: 426–441. doi: 10.1007/s12020-017-1278-5

03-09-2017 | Osteoporosis | Review | Article

Obesity, type 2 diabetes, and bone in adults

Walsh JS, Vilaca T. Calcif Tissue Int 2017; 100: 528–535. doi: 10.1007/s00223-016-0229-0

Image Credits